Acarix AB (publ) (ACIXF)
OTCMKTS · Delayed Price · Currency is USD
0.0330
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Acarix AB Revenue
Acarix AB had revenue of 2.35M SEK in the quarter ending September 30, 2025, with 136.66% growth. This brings the company's revenue in the last twelve months to 6.92M, up 21.88% year-over-year. In the year 2024, Acarix AB had annual revenue of 6.20M, down -0.62%.
Revenue (ttm)
6.92M SEK
Revenue Growth
+21.88%
P/S Ratio
57.87
Revenue / Employee
864.88K SEK
Employees
8
Market Cap
42.49M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.20M | -39.00K | -0.62% |
| Dec 31, 2023 | 6.24M | 419.00K | 7.20% |
| Dec 31, 2022 | 5.82M | 2.06M | 54.84% |
| Dec 31, 2021 | 3.76M | 1.59M | 73.27% |
| Dec 31, 2020 | 2.17M | 313.00K | 16.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| QHSLab | 2.61M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
Acarix AB News
- 3 months ago - Acarix AB (publ) (ACIXF) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 1 year ago - Acarix AB (publ) publishes Interim Report, April - June 2024 - PRNewsWire
- 1 year ago - Acarix Shares Begin Trading on the US-based OTCQB Market - PRNewsWire